The second most common male cancer is prostate cancer (PCa), which has a high tendency
for bone metastasis. Long non-coding RNAs, including TMPO-AS1, play a crucial role in …

Background Prostate cancer (PCa) is a leading cause of death in males all over the world;
besides, the diagnosis and therapy of it are still challenging. Researchers have revealed …

Osteosarcoma (OS) is a common kind of aggressive tumor in bone which was mostly
identified in children and adolescents with extremely high risk of death. Accumulating …

Background Thyroid cancer (TC) is the most frequent endocrine malignancy. Long
noncoding RNAs (lncRNAs) have been confirmed to act as significant roles in tumor …

Background Bone metastasis is the leading cause of tumor‐related death in prostate cancer
(PCa) patients. Long noncoding RNAs (lncRNAs) have been well documented to be …

Bone metastasis is associated with cancer‐related death in patients with prostate cancer
(PCa). Long noncoding RNAs (lncRNAs) play critical roles in tumor progression of PCa …

OBJECTIVE: This study aims to explore the clinical value and mechanism of lncRNA-TMPO-
AS1 in osteosarcoma. PATIENTS AND METHODS: We collected 51 samples of cancer …

OBJECTIVE: This study aims to uncover the in vitro influences of lncRNA TMPO-AS1 on the
progression of bladder cancer (BLCA) and the underlying mechanism. PATIENTS AND …

Osteosarcoma (OS) originating from mesenchyme is one of the most common invasive
tumors of bone, and has an extremely high mortality rate. Previous studies have reported …

Background: Recent studies have proven that abnormal expression of long noncoding
RNAs (lncRNAs) often contributes to growth and invasion of cancer cells. The purpose of …